J-Ring M Tablet ER
221,20 ₹
Analogs of J-Ring M Tablet ER
Find cheaper analogs and generic equivalents for J-Ring M Tablet ER.
Princípio ativo: Metformin; Teneligliptin
Visão geral do produto
About J-Ring M Tablet ER
J-Ring M Tablet ER is a medication containing the active ingredient Metformin, classified as Medication used to treat diabetes. Metformin, sold under the brand name Glucophage, among others, is the main first-line medication for the treatment of type 2 diabetes, particularly in people who are overweight. It is also used in the treatment of polyendocrine metabolic ovarian syndrome, and is sometimes used as an off-label adjunct to lessen the ris….
Key Benefits & Uses
- Used for: 1 INDICATIONS AND USAGE ZITUVIMET is a combination of sitagliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor, and metformin hydrochloride (HCl), a.
- Used for: ( 1 ) Limitations of Use: ZITUVIMET is not rec…
- Use only as directed on the product label or by a healthcare professional.
Active Ingredient & Action
Metformin, the active ingredient in J-Ring M Tablet ER, belongs to the Medication used to treat diabetes class. 1 INDICATIONS AND USAGE ZITUVIMET is a combination of sitagliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor, and metformin hydrochloride (HCl), a biguanide, indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. ( 1 ) Limitations of Use: ZITUVIMET is not rec…. Inactive ingredients: not listed in source data.
Important Notes
Always read and follow the label instructions carefully before taking J-Ring M Tablet ER. If you have any underlying medical conditions, are taking other medicines, or are pregnant or breastfeeding, consult a doctor or pharmacist before use. Do not exceed the recommended dose on the package and do not use J-Ring M Tablet ER for extended periods without medical advice.
Find in Pharmacies
Compare local prices and distance for J-Ring M Tablet ER.
Visitor ratings
Help others by rating how useful this product page is.
No ratings yet — be the first.